Valid Ghana · FDA Ghana

PELAFEN EXTRA TABLETS

DICLOFENAC SODIUM+PARACETAMOL+CAFFEINE

FDA/SD.243-040560 TABLETS 50MG+325MG+30MG

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/SD.243-040560
Registration date
2024-04-03
Expiry date
2027-05-01
Status
Valid
Active ingredient
DICLOFENAC SODIUM+PARACETAMOL+CAFFEINE
Dosage form
TABLETS
Strength
50MG+325MG+30MG
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Mercury Laboratory
Applicant / LTR
PENAK PHARMACY LIMITED; P.O BOX SE 1276, SUAME-KUMASI, GHANA
Country of origin
INDIA
Manufacturer location
Halol - Vadodara Rd, Jarod, Vadodara, Gujarat 391510, India

Source: Food and Drugs Authority · fetched 2026-04-18 08:37:09 · updated 2026-10-23 04:00:07

Drug Interactions

25
Check interactions

Severe (1)

Mifamurtide - decreases efficacy

NSAIDs(high-dose)arepredictedtodecreasetheefficacyof mifamurtide.Avoid.rTheoretical

Severe Theoretical

Moderate (8)

Antiarrhythmics - increases exposure

NSAIDs (celecoxib) are predicted to increase the exposure to antiarrhythmics (flecainide, propafenone). Monitor and adjust dose.

Moderate Theoretical

Cladribine - increases exposure

NSAIDs(sulindac)mightincreasetheexposuretocladribine. Avoidoradjustdose.oTheoretical

Moderate Theoretical

Flecainide - increases exposure

NSAIDs (celecoxib) are predicted to increase the exposure to antiarrhythmics (flecainide, propafenone). Monitor and adjust dose.

Moderate Theoretical

Pemetrexed - increases exposure

NSAIDs are predicted to increase the exposure to pemetrexed. Use with caution or avoid. Also see TABLE 2 p. 1517

Moderate Theoretical

Prilocaine - increases risk of methaemoglobinaemia

Paracetamol is predicted to increase the risk of methaemoglobinaemia when given with topical anaesthetics, local (prilocaine). Use with caution or avoid.

Moderate Theoretical

Propafenone - increases exposure

NSAIDs (celecoxib) are predicted to increase the exposure to antiarrhythmics (flecainide, propafenone). Monitor and adjust dose.

Moderate Theoretical

Topical Anaesthetics, Local - increases risk of methaemoglobinaemia

Paracetamol is predicted to increase the risk of methaemoglobinaemia when given with topical anaesthetics, local (prilocaine). Use with caution or avoid.

Moderate Theoretical

Topical Prilocaine - increases risk of methaemoglobinaemia

Paracetamolispredictedtoincreasetheriskof methaemoglobinaemiawhengivenwithtopicalprilocaine. Usewithcautionoravoid.rTheoretical 1xidneppA|snoitcaretnI A1 https://www.facebook.c (Books-Courses-Medic

Moderate Theoretical

Unknown (16)

Alendronate - increases risk of gastrointestinal irritation

NSAIDs are predicted to increase the risk of gastrointestinal irritation when given with bisphosphonates (alendronate, ibandronate).

Unknown Study

Bisphosphonates - increases risk of gastrointestinal irritation

NSAIDs are predicted to increase the risk of gastrointestinal irritation when given with bisphosphonates (alendronate, ibandronate).

Unknown Study

Bisphosphonates - increases risk of renal impairment

NSAIDs are predicted to increase the risk of renal impairment when given with bisphosphonates (clodronate).

Unknown Study

Clodronate - increases risk of renal impairment

NSAIDs are predicted to increase the risk of renal impairment when given with clodronate.

Unknown Study

Coumarins - increases anticoagulant effect

Paracetamol increases the anticoagulant effect of coumarins.

Unknown Study

Data from BNF 85 (British National Formulary). This is not a substitute for professional medical advice. Matched via: class

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.